Differential effects of amphetamine and neuroleptics on negative Vs. positive symptoms in schizophrenia
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Positive symptoms of schizophrenia were diminished by neuroleptics and increased by amphetamine and accounted for most of the change seen in the total Brief Psychiatric Rating Scale (BPRS). Negative symptoms in the same subjects were not affected by neuroleptics but increased after amphetamines to a degree that just attained statistical significance. This increase was due to one item (emotional withdrawal) of the negative symptom factor which responded to neuroleptics and amphetamines as did positive symptoms. These findings are discussed with respect to new ideas about the role of dopamine in schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Administration of stimulants to unmedicated schizophrenic patients can enhance positive symptoms (Angrist et al 1980, van Kammen et al 1982), which is likely due to subcortical D2 receptor activation.”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Angrist et al 1980, van Kammen et al 1982
Citations
Cites
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,856
CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA
Johnstone, E., Frith, C. D., Crow, T. J., Husband, J., & Kreel, L. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90890-4 · Cited by 1,253
The Dopamine Hypothesis of Schizophrenia: A Review*
Meltzer, H. Y., & Stahl, S. M. (1976) · Schizophrenia Bulletin · doi:10.1093/schbul/2.1.19 · Cited by 883
Kono, R., Miyamura, K., OGINO, T., Wadia, N. H., Wadia, P. N., Sm, K., & Vp, M. (1981) · PubMed · Cited by 578
MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA
Johnstone, E., Frith, C. D., Crow, T. J., Carney, M. W. P., & Price, J. S. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90193-9 · Cited by 458
Hormones, Behavior, and Psychopathology
SACHAR, E. J. (1977) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197709000-00013 · Cited by 330
Weinberger, D. R. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140013001 · Cited by 323
The dementia of dementia praecox
Johnstone, E. C., Crow, T. J., Frith, C. D., Stevens, M., Kreel, L., & Husband, J. (1978) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1978.tb06899.x · Cited by 270
Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00427592 · Cited by 140
Self-citation
Research works printed but not linked: 1
- Guy W (1976) E.C.D.E.U. assessment manual for psychopathology. Washington D.C.: U.S. Department of Health, Education and Welfare, pp 160, 162, 167
Cited by
Items 201–300 of 371
The glutamate hypothesis of schizophrenia
Akhondzadeh, S. (1998) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.1998.00160.x · Cited by 18
Sulpiride in negative schizophrenia: A placebo‐controlled double‐blind assessment
Soni, S. D., Mallik, A., & Schiff, A. A. (1990) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470050308 · Cited by 18
Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia
Kanof, P. D., Davidson, M., Johns, C. A., Mohs, R. C., & Davis, K. L. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.12.1556 · Cited by 18
Effect of Neuroleptics on the Schizophrenic Syndrome
Meltzer, H. Y. (1987) · Springer eBooks · doi:10.1007/978-3-642-71288-3_30 · Cited by 18
Lévy, F. (1993) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1993.tb00504.x · Cited by 18
Hada, K., Wulaer, B., Nagai, T., Itoh, N., Sawahata, M., Sobue, A., Mizoguchi, H., Mori, D., Kushima, I., Nabeshima, T., et al. (2021) · Molecular Brain · doi:10.1186/s13041-021-00735-4 · Cited by 17
Long-Term Monomorphism of Negative and Positive Schizophrenic Episodes
Marneros, A., Deister, A., & Rohde, A. (1991) · Springer eBooks · doi:10.1007/978-3-642-76841-5_12 · Cited by 17
Mazindol Treatment of Negative Symptoms
Carpenter, W. T., Breier, A., Buchanan, R. W., Kirkpatrick, B., Shepard, P., & Weiner, E. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00115-9 · Cited by 16
Grace, A. A. (2003) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2003.10.014 · Cited by 16
Effects of mianserin in chronic schizophrenia
Mizuki, Y., Kajimura, N., Kai, S., 末次, 正., Ushijima, I., & Yamada, M. (1992) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(92)90057-l · Cited by 16
The relationship of tardive dyskinesia to positive Schizophrenia
Sandyk, R., & Kay, S. R. (1991) · International Journal of Neuroscience · doi:10.3109/00207459108985409 · Cited by 16
Verbal hallucinations also occur in normals
Posey, T. B. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046951 · Cited by 16
Moroji, T., ITOH, K., & Itoh, K. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb29945.x · Cited by 16
Willis, G. L., & Armstrong, S. M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00013-7 · Cited by 15
MDL 100,907: A Selective 5‐HT2A Receptor Antagonist for the Treatment of Schizophrenia
Schmidt, C. J., Kehne, J. H., & Carr, A. A. (1997) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1997.tb00316.x · Cited by 14
The Ethological Analysis of Monkeys in a Social Setting as an Animal Model for Schizophrenia
Ellenbroek, B. A. (1991) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-6419-0_26 · Cited by 14
In what context is latent inhibition relevant to the symptoms of schizophrenia?
Frith, C. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065158 · Cited by 14
Premorbid social competence and the effectiveness of early neuroleptic treatment
Glick, M., Mazure, C. M., Bowers, M. B., & Zigler, E. (1993) · Comprehensive Psychiatry · doi:10.1016/0010-440x(93)90064-b · Cited by 13
Castellon, S. A., Asarnow, R. F., Goldstein, M. J., & Marder, S. R. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90065-5 · Cited by 13
Depression in schizophrenia: Current guidelines to treatment
Bartels, S. J., & Drake, R. E. (1989) · Psychiatric Quarterly · doi:10.1007/bf01064357 · Cited by 13
Zur Stabilität negativer und positiver Syndromatik
Deister, A., Marneros, A., & Rohde, A. (1990) · Springer eBooks · doi:10.1007/978-3-642-76263-5_3 · Cited by 13
Verbal hallucinations, unintendedness, and the validity of the schizophrenia diagnosis
Bentall, R. P., & Slade, P. D. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046823 · Cited by 13
Turgeon, S. M., & Roche, J. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00715-5 · Cited by 13
Lewine, R. R. J. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.361 · Cited by 13
Neurohumoural and Structural Changes in Schizophrenia: Two Dimensions of Pathology
Crow, T. J. (1982) · Progress in brain research · doi:10.1016/s0079-6123(08)64211-9 · Cited by 12
Enlarged Cerebral Ventricles in Schizophrenia
Weinberger, D. R., & Wyatt, R. J. (1983) · Psychiatric Annals · doi:10.3928/0048-5713-19830501-06 · Cited by 12
Visual search, EEG, and psychopathology in schizophrenic patients
Gäebel, W. (1989) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf01739744 · Cited by 12
Positive and Negative Schizophrenic Symptoms
Freeman, T. (1982) · The British Journal of Psychiatry · doi:10.1192/bjp.140.2.210b · Cited by 12
A hippocampal theory of schizophrenia
Schmajuk, N. A., & DiCarlo, J. J. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065353 · Cited by 12
Schizophrenia: A Multidimensional Disorder
Opler, L. A., & Hwang, M. Y. (1994) · Psychiatric Annals · doi:10.3928/0048-5713-19940901-12 · Cited by 11
Saletu, B., Anderer, P., Semlitsch, H. V., Grünberger, J., Linzmayer, L., & Chaudhry, H. R. (1992) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(92)90039-7 · Cited by 10
Halter, C. A., Bond, G. R., & Graaf-Kaser, R. D. (1992) · Community Mental Health Journal · doi:10.1007/bf00756700 · Cited by 10
Neuropsychological vulnerability or episode factors in schizophrenia?
Nuechterlein, K. H., & Green, M. F. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065250 · Cited by 10
(Potentielle) Antipsychotika mit neuartigen Wirkmechanismen
Kornhuber, J. (1992) · Springer eBooks · doi:10.1007/978-3-7091-3282-1_5 · Cited by 10
Why don't preschizophrenic children have delusions and hallucinations?
Pilowsky, L. S., & Murray, R. M. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065298 · Cited by 10
Bases for irrelevant information processing in schizophrenia: Room for manoeuvre
Oades, R. D. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065262 · Cited by 10
How have developments in molecular imaging techniques furthered schizophrenia research?
Thompson, J. L., Urban, N., & Abi‐Dargham, A. (2009) · Imaging in Medicine · doi:10.2217/iim.09.22 · Cited by 9
Hearing voices and the bicameral mind
Jaynes, J. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046914 · Cited by 9
Madianos, M. G., & Economou, M. P. (1988) · International Journal of Mental Health · doi:10.1080/00207411.1988.11449079 · Cited by 9
Options for the Treatment of Negative Symptoms of Schizophrenia
Coffey, I. (1994) · CNS Drugs · doi:10.2165/00023210-199401020-00003 · Cited by 9
Sengel, R. A., Lovallo, W. R., & Pishkin, V. (1985) · Comprehensive Psychiatry · doi:10.1016/0010-440x(85)90037-9 · Cited by 9
Hallucination, rationalization, and response set
Schwartz, S. S. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046987 · Cited by 9
Image or neural coding of inner speech and agency?
Zivin, G. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047002 · Cited by 9
Motivational Impairment in Primary Psychiatric and Medical Illness
Krupp, B. H., & Fogel, B. S. (1997) · Psychiatric Annals · doi:10.3928/0048-5713-19970101-09 · Cited by 9
Gross, G., & Huber, G. (1984) · Springer eBooks · doi:10.1007/978-3-642-69539-1_7 · Cited by 9
Neurobiochemie, Wirkungsmechanismen
Fritze, J. (1992) · Springer eBooks · doi:10.1007/978-3-7091-3282-1_3 · Cited by 9
A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) in schizophrenia
Mizuki, Y., Nishikori, S., Kajimura, N., Imaizumi, J., Yamada, M., & Inanaga, K. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90204-5 · Cited by 8
An Outline of Hazardous Side Effects of Ritalin (Methylphenidate)
Scarnati, R. A. (1986) · International Journal of the Addictions · doi:10.3109/10826088609027396 · Cited by 8
Arousal and the disruption of language production processes in schizophrenia
Gjerde, P. F. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046872 · Cited by 8
Treatment of negative schizophrenia with d-amphetamine
Desai, N. G., Gangadhar, B. N., Pradhan, N., & Channabasavanna, S. M. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.723 · Cited by 8
Neuropsychology of schizophrenia: The “hole” thing is wrong
Swerdlow, N. R. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065389 · Cited by 8
The diversity of the schizophrenias
Faber, R. A. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046859 · Cited by 8
Dexamphetamine reduces auditory P3 delta power and phase-locking while increasing gamma power
Albrecht, M. A., Price, G. W., Lee, J. J., Iyyalol, R., & Martin-Iverson, M. T. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.02.009 · Cited by 7
The early identification of psychosis: can lessons be learnt from cardiac stress testing?
Gupta, S., Ranganathan, M., & D’Souza, D. C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4143-3 · Cited by 7
Chronic Schizophrenia: The Major Mental Health Problem of the Century
Gomez, G. E., & Gómez, E. A. (2009) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.1991.tb00326.x · Cited by 7
A faulty negative feedback control underlies the schizophrenic syndrome?
Carlsson, A., & Carlsson, M. L. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065067 · Cited by 7
Verbal hallucinations and speech disorganization in schizophrenia: A further look at the evidence
Harrow, M., Marengo, J. T., & Ragin, A. B. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046902 · Cited by 7
Teleology and agency in speech production
Gordon, R. M. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046884 · Cited by 7
When is an image hallucinatory?
Reed, G. F. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046963 · Cited by 7
Lexical access and discourse planning: Bottom-up interference or top-down control troubles?
Lehnert, W. G. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046938 · Cited by 7
Hutson, P. H., Rowley, H. L., Gosden, J., Kulkarni, R. S., Slater, N., Love, P. L., Wang, Y., & Heal, D. J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.014 · Cited by 6
Interpersonal violence and mental illness
Rossi, A., & Talevi, D. (2017) · Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila · Cited by 6
Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients
Swerdlow, N. R., Bhakta, S. G., Talledo, J., Benster, L. L., Kotz, J. E., Lavadia, M. L., & Light, G. A. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0495-4 · Cited by 6
Dopaminergic Hypothesis of Schizophrenia: A Historical Perspective
Jučaitė, A., & Nyberg, S. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch1 · Cited by 6
What can schizophrenic “voices” tell us?
Hoffman, R. E. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047014 · Cited by 6
Bagdy, G., Perényi, G., Frecska, E., Seregi, A., Fekete, M. I. K., Tóthfalusi, L., Magyar, K., Bela, A., & Arató, M. (1988) · Journal of Neural Transmission · doi:10.1007/bf01259412 · Cited by 6
Heterogeneity, orienting and habituation in schizophrenia
Dawson, M. E., & Hazlett, E. A. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065110 · Cited by 6
Angrist, B., Rotrosen, J., & Gershon, S. (2001) · Psychopharmacology · doi:10.1007/s002130100854 · Cited by 6
Self-citationMotor disturbances in schizophrenia
Crider, A. B. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065092 · Cited by 6
Schizophrenia and attention: In and out of context
Lubow, R. E. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065237 · Cited by 6
The accumbens–substantia nigra pathway, mismatch and amphetamine
Weiner, I. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065407 · Cited by 6
The neuropsychology of schizophrenia: A perspective from neurobehavioral genetics
Crusio, W. E. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065109 · Cited by 5
Amineptine dependence and schizophrenia
Prieto, J. M., Gost, A., Obiols, J. E., & Caycedo, N. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90608-4 · Cited by 5
Speech errors and hallucinations in schizophrenia – no difference?
Harley, T. A. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046896 · Cited by 5
Psychological and Psychiatric Consequences of Amphetamines
Wyatt, S. A., & Ziedonis, D. M. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2913-9_33 · Cited by 5
Intended versus intentional action
Brand, M. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046835 · Cited by 5
Wirkung von Flupentixol auf Negativsymptomatik und depressive Syndrome bei schizophrenen Patienten
Bandelow, B. (1998) · Steinkopff eBooks · doi:10.1007/978-3-642-93700-2_5 · Cited by 5
Effect of apomorphine infusion on plasma homovanillic acid in normal subjects
Davidson, M., Kendler, K. S., Mohs, R. C., Hollander, E., Ryan, T. M., & Davis, K. L. (1986) · Journal of Psychiatric Research · doi:10.1016/0022-3956(86)90012-9 · Cited by 5
Excitatory amino acids, NMDA and sigma receptors: A role in schizophrenia?
Jansen, K. L. R., & Faull, R. L. M. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065225 · Cited by 5
Landmark publications in Psychopharmacology: the first 40 years
Miczek, K. A. (2001) · Psychopharmacology · doi:10.1007/s002130000675 · Cited by 5
How does the physiology change with symptom exacerbation and remission in schizophrenia?
Dougherty, G. G., Steinhauer, S. R., Zubin, J., & van Kammen, D. P. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065122 · Cited by 5
Novelty value in associative learning
Gewirtz, J. C. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0006516x · Cited by 5
A three-component analysis of Hoffman's model of verbal hallucinations
Allen, H. A. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0004680x · Cited by 5
Die Bedeutung der verschiedenen Neuroleptikagruppen unter dem Aspekt von Neuroleptika-Nonresponse
Tegeler, J. (1993) · Springer eBooks · doi:10.1007/978-3-7091-9292-4_11 · Cited by 5
Differentielle Indikationen der neuroleptischen Akutbehandlung Schizophrener
Tegeler, J. (1987) · Springer eBooks · doi:10.1007/978-3-642-83188-1_6 · Cited by 5
Parkinsonoid, Akinese, negative und depressive Symptomatik bei schizophrenen Erkrankungen
Gäebel, W. (1993) · Springer eBooks · doi:10.1007/978-3-642-78040-0_7 · Cited by 5
Verhoeven, W. M. A. (1985) · Nordic Journal of Psychiatry · doi:10.3109/08039488509106141 · Cited by 4
Deese, J. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046847 · Cited by 4
Möller, H.-J., & Rao, M. L. (1996) · Springer eBooks · doi:10.1007/978-3-642-61076-9_14 · Cited by 4
Genetic and functional investigation of FXYD6 and MAP2K7 as risk factors in schizophrenia
Thompson, R. (2013) · Enlighten: Theses (The University of Glasgow) · Cited by 4
The role of long-term memory (LTM) and monitoring in schizophrenia: Multiple functions
Harrow, M., & Silverstein, M. L. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065183 · Cited by 4
Intentionality and autonomy of verbal imagery in altered states of consciousness
Marks, D. F. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0004694x · Cited by 4
The mechanism of positive symptoms in schizophrenia
Hoffman, R. E. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065201 · Cited by 4
Schizophrénie : La prescription des neuroleptiques antiproductifs et antidéficitaires en France
Lecrubier, Y. (1986) · Psychiatry and Psychobiology · doi:10.1017/s0767399x00003229 · Cited by 4
Positive and Negative Symptomatology: The State of Affairs
Marneros, A., & Andreasen, N. C. (1991) · Springer eBooks · doi:10.1007/978-3-642-76841-5_26 · Cited by 4
Positive versus Negative Schizophrenia: Criteria and Validation
Andreasen, N. C. (1985) · Springer eBooks · doi:10.1007/978-1-4899-5049-9_79 · Cited by 3
Sense and non-sense of polypharmacy: increasing efficacy, decreasing compliance?
Boyer, P. (2003) · European Psychiatry · doi:10.1016/s0924-9338(03)80006-8 · Cited by 3
Approximations to a neuropsychological model of schizophrenia
Manschreck, T. C., & Maher, B. A. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065249 · Cited by 3
Psychopharmacological challenge studies in psychiatric research
D’Souza, D. C., & Krystal, J. H. (2001) · International Review of Psychiatry · doi:10.1080/09540260020024187 · Cited by 3
Reduction of Cerebral Blood Flow in Chronic Schizophrenia: Relation to Age
Kanoh, M., Kamioka, Y., & Takahashi, S. (1992) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1992.tb00825.x · Cited by 3
Metadata
- Authors
- Angrist, B., Rotrosen, J., & Gershon, S.
- Affiliations
- United States Department of Veterans Affairs (US)
- Wayne State University (US)
- ORCID
- Rotrosen, J.
- Venue
- Psychopharmacology
- Published
- 1980-12
- Volume
- 72
- Issue
- 1
- Pages
- 17-19
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2050121560
- Cited by
- 344
- References
- 11
- Citations by year
- 2026: 1 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 2 · 2013: 4 · 2012: 8
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- amphetamine, antipsychotic drugs, schizophrenia, negative symptoms, positive symptoms, Brief Psychiatric Rating Scale, emotional withdrawal, dopamine, psychopharmacological effects
- MeSH terms
- Adult, Affect, Dextroamphetamine, Dopamine, Female, Haloperidol, Humans, Male, Psychiatric Status Rating Scales, Schizophrenia, Schizophrenic Psychology, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.